Molecule of the month. FDA approves new treatment for fibromyalgia.
Lindsley
Craig W
CW
Department of Pharmacology, Vanderbilt University Medical Center, Nashville, TN 37232-6600, USA.
D003521:Cyclopropanes / Q000627:therapeutic use*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D005356:Fibromyalgia / Q000188:drug therapy*; D006801:Humans; D000078764:Milnacipran; D014481:United States; D014486:United States Food and Drug Administration
D003521:Cyclopropanes; D000078764:Milnacipran